Autres langues Botanix Pharmaceuticals Limited

Actions

BOT

AU000000BOT2

Marché Fermé - Australian S.E. Autres places de cotation 08:10:05 29/04/2024			Varia. 5j.	Varia. 1 janv.
0,22 ^AUD	+4,76 %		0,00 %	+15,79 %

27/02	Botanix Pharmaceuticals Limited publie ses résultats pour le semestre clos le 31 décembre 2023	CI
22/01	La FDA américaine accepte la resoumission du médicament topique de Botanix Pharmaceuticals	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Botanix Pharmaceuticals Limited(ASX:BOT) added to S&P/ASX All Ordinaries Index	18/03
Botanix Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	27/02
US FDA Accepts Resubmission of Botanix Pharmaceuticals' Topical Medication	22/01
Botanix Pharmaceuticals Completes US FDA Resubmission for Topical Medication; Shares Gain 3%	21/12
Botanix Pharmaceuticals Completes Human Factors Validation Study for Topical Medication; Shares Rise 3%	14/12
Botanix Pharmaceuticals Secures US FDA Feedback for Topical Medication	04/12
Botanix Pharmaceuticals Limited Receives Feedback from FDA	03/12
Botanix Pharmaceuticals Completes Nearly AU$14 Million Institutional Placement	01/12
Botanix Pharmaceuticals to Raise AU$13.5 Million in Placement; Shares Fall 3%	27/11
Acne Vulgaris Pipeline\| Clinical Trials, Key Companies - Novan, Bausch Health AOBiome, Ascletis Pharmaceuticals, AnaptysBio, Botanix Pharmaceuticals	07/11
Moderate to Severe Inflammatory Acne Vulgaris Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)	27/10/23
Botanix Pharmaceuticals Signs Telehealth Deal for Dermatological Product	24/10/23
Botanix Pharmaceuticals Secures Conditional US FDA Clearance for Use of 'Sofra' Trade Name	17/10/23
Botanix Pharmaceuticals Limited(ASX:BOT) added to S&P/ASX Emerging Companies Index	18/09/23
Botanix Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
Botanix Pharmaceuticals Promotes COO to CEO	25/08/23
Botanix Pharmaceuticals Limited Appoints Howie Mckibbon as Chief Executive Officer	25/08/23
Fresh Tracks Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update	14/08/23
Fresh Tracks Announces $8.25 Million Buyout of Its Right to Receive Future Sofpironium Bromide Payments from Botanix	24/07/23
CapitalGainsReport Penny Stock Bounce List: EPAZ, ARDS, FRTX, GNPX	24/07/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Botanix Pharmaceuticals Limited

Actions

BOT

AU000000BOT2

Autres langues

Filtres